Altimmune (ALT) Return on Sales Growth (3y) (2013 - 2025)
Altimmune (ALT) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Altimmune | 7.96 Mn | 7.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3,288.00 |
| Sep 30, 2025 | 7,955.00 |
| Jun 30, 2025 | -1,913.00 |
| Mar 31, 2025 | -3,303.00 |
| Dec 31, 2024 | -4,634.00 |
| Sep 30, 2024 | -4,357.00 |
| Jun 30, 2024 | -4,747.00 |
| Mar 31, 2024 | -4,861.00 |
| Dec 31, 2023 | -849.00 |
| Sep 30, 2023 | -51.00 |
| Jun 30, 2023 | -2,813.00 |
| Mar 31, 2023 | -960.00 |
| Dec 31, 2022 | -364.00 |
| Sep 30, 2022 | -11,741.00 |
| Jun 30, 2022 | -2,514.00 |
| Mar 31, 2022 | -611.00 |
| Dec 31, 2021 | 8.00 |
| Sep 30, 2021 | -211.00 |
| Jun 30, 2021 | -177.00 |
| Mar 31, 2021 | -17.00 |